The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
p53 in ferroptosis regulation: the new weapon for the old guardian
Open accessAbstract
Although the conventional activities of p53 such as cell cycle arrest, senescence, and apoptosis are well accepted as the major checkpoints in stress responses, accumulating evidence implicates the importance of other tumor suppression mechanisms. Among these unconventional activities, an iron-dependent form of non-apoptotic cell death, termed ferroptosis, attracts great interest. Unlike apoptotic cell death, activation of p53 alone is not sufficient to induce ferroptosis directly; instead, through its metabolic targets, p53 is able to modulate the ferroptosis response in the presence of ferroptosis inducers such as GPX4 inhibitors or high levels of ROS. Here, we review the role of ferroptosis in p53-mediated tumor suppression, with a focus on what cellular factors are critical for p53-dependent ferroptosis during tumor suppression and how p53 modulates both the canonical (GPX4-dependent) and the non-canonical (GPX4-independent) ferroptosis pathways. We also discuss the possibility of targeting p53-mediated ferroptotic responses for the treatment of human cancers and potentially, other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It is known that p53 modulates ferroptosis, an iron-dependent, nonapoptotic form of cell death induced by lipid peroxidation in response to high levels of ROS [ 71 ].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ma, S., Sun, L., Wu, W., Jiang-li, W., Sun, Z., & Ren, J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.551318 · Cited by 202
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Ferroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,973
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2239 · Cited by 4,293
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Bersuker, K., Hendricks, J. M., Li, Z., Magtanong, L., Ford, B., Tang, P. H., Roberts, M. A., Tong, B., Maimone, T. J., Zoncu, R., et al. (2019) · Nature · doi:10.1038/s41586-019-1705-2 · Cited by 3,703
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Self-citationFSP1 is a glutathione-independent ferroptosis suppressor
Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., Goya Grocin, A., Xavier da Silva, T. N., Panzilius, E., Scheel, C. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1707-0 · Cited by 3,341
Research works printed but not linked: 1
- Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57–62. · DOI · Paper page
Cited by
Sorted by citations
Items 301–400 of 540
Gnanamony, M., Thomas, M., Nguyen, T. H., Brownstein, K. J., & de Alarcón, P. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083600 · Cited by 7
Wang, Z., Lu, J., Liu, C., Liang, X., Zeng, P.-H., & Lu, F. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120227 · Cited by 6
Bidzińska, J., Pietro, L. D., Naghshineh, E., Pandini, C., Doria, F., Zaffaroni, N., Gandellini, P., Neidle, S., & Folini, M. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07908-2 · Cited by 8
Molecular and Clinical Insights into TP53-Mutated MDS and AML
Georgantzinos, E., & Karantanos, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210818 · Cited by 7
Oxidative Stress‐Related Programmed Cell Death in Male Infertility: Focussing on Ferroptosis
Ata-abadi, N. S., Aboutalebi, F., Dormiani, K., & Nasr‐Esfahani, M. H. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71002 · Cited by 8
Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy
Scattolin, T., Cavarzerani, E., Alessi, D. R., Mauceri, M., Botter, E., Tonon, G., Caligiuri, I., Repetto, O., Kamenšek, U., Kranjc, S., et al. (2025) · Dalton Transactions · doi:10.1039/d5dt00194c · Cited by 7
Mutant p53K120R expression enables a partial capacity to modulate metabolism
Monti, P., Ravera, S., Speciale, A., Velkova, I., Foggetti, G., Degan, P., Fronza, G., & Menichini, P. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.974662 · Cited by 7
Tumor Suppressor p53 Down-Regulates Programmed Cell Death Protein 4 (PDCD4) Expression
Yang, W. H., George, A. P., Wang, C., Yang, R. H., Duncan, A. M., Patel, D., Neil, Z. D., & Yang, W. (2023) · Current Oncology · doi:10.3390/curroncol30020124 · Cited by 6
Ao, X., Jiang, T., Li, Y., Lai, W., Lian, Z., Wang, L., Huang, M., & Zhang, Z. (2023) · iScience · doi:10.1016/j.isci.2023.108721 · Cited by 7
Bedolla, N., Liu, L., Liu, X., Xie, Q., & Ren, Y. (2025) · Toxicon · doi:10.1016/j.toxicon.2025.108233 · Cited by 6
Cai, L., Li, S., Wan, C., Xu, B., Huang, H., & Xu, L. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114373 · Cited by 6
Jia, X., Shi, Y., Su, J., Zhou, Y., Li, W., Li, Y., Di, B., An, F., & Yan, C. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115876 · Cited by 6
Kourti, M., & Kontoghiorghes, G. J. (2025) · Antioxidants · doi:10.3390/antiox15010015 · Cited by 11
Li, H. M., Chen, G., Ma, C., Hu, Y., Zhou, P., Zhou, S., & Wen, H. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110306 · Cited by 6
Song, C., Li, D., Huang, L., Zhang, J., & Zhao, X. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00140 · Cited by 6
Chlormequat Chloride Inhibits TM3 Leydig Cell Growth via Ferroptosis-Initiated Inflammation
Wang, X., Kang, C., Guo, W., Zhang, H., Xiao, Q., & Hao, W. (2024) · Cells · doi:10.3390/cells13110979 · Cited by 6
Fan, J. K., Xue, L., Lin, H., & Luo, J. (2024) · Cell Division · doi:10.1186/s13008-024-00128-8 · Cited by 6
Fan, L., Guo, D., Zhu, C., Gao, C., Wang, Y., Yin, F., Liu, M., Zhou, Y., Wei, T., Xiong, X., et al. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.11.001 · Cited by 6
Chen, J., Li, W., Zhang, C., Wen, D., & Cheng, J. (2024) · Discover Oncology · doi:10.1007/s12672-024-01586-w · Cited by 6
Cao, S., Wei, Y., Yue, Y., Wang, D., Xiong, A., & Zeng, H. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.104222 · Cited by 6
Liu, K., Chen, H., Wang, Y., Jiang, L., & Li, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.846864 · Cited by 7
Luo, J., Pei, J., Yu, C., Tian, X., Zhang, J., Shen, L., Hua, Y., & Wei, G. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2257801 · Cited by 6
You, Y., Zhou, X., Tang, Q., Zhao, T., Wang, J., Huang, H., Chen, J., Qi, Z., & Li, F. (2024) · Aging · doi:10.18632/aging.205622 · Cited by 6
Sirtuin 1 in regulating the p53/glutathione peroxidase 4/gasdermin D axis in acute liver failure
Katoch, S., & Patial, V. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i34.3850 · Cited by 6
Vitamin C Inhibits Scale Drop Disease Virus Infectivity by Targeting Nrf2 to Reduce Ferroptosis
Chen, J., Fu, Y., Weng, S., He, J., & Dong, C. (2025) · Antioxidants · doi:10.3390/antiox14050576 · Cited by 5
Ferroptosis in osteogenic differentiation: a narrative review of bone regeneration metabolism
Huang, L., Wang, J., Xu, J., Bian, M., Wang, J., & Lu, S. (2025) · Regenerative medicine reports . · doi:10.4103/regenmed.regenmed-d-25-00007 · Cited by 6
Song, C., Huang, L., Li, D., & Zhao, X. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c08388 · Cited by 5
Ferroptosis: a novel therapeutic warrior in the battle against leukemia
Bai, Y., Luo, Y., Yuan, Y., Li, X., Jin, J., Ping, R., Guo, J., Jin, L., Yu, Y., & Xiong, Y. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02130-z · Cited by 5
Ibrahim, L., Mohamed, R. H., Tolba, M. M., Radwan, S. M., Hamdy, N. Μ., & ElHefnawi, M. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01630-0 · Cited by 6
Li, Z., Ma, J., Guan, H., Lai, J., Xu, F., & Cao, G. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10073-z · Cited by 5
Li, X., Zheng, W., Luo, Z., Zhang, X., Huang, H.-T., Liao, G., Liang, H., Wen, W., Jiang, Y., Zhuang, H., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157175 · Cited by 5
Yu, Y., Luan, M., Zang, J., Luo, L., Wang, T., Wang, T., Wang, Y., & Wang, H. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07985-3 · Cited by 5
Ferroptosis in Diabetic Cardiomyopathy and Atherosclerosis: Mechanisms and Clinical Prospects
Huang, W., Han, X., Meng, Z., Chen, X., Lü, A., & Cheung, K. C.-P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110661 · Cited by 5
Sharma, A., Srivastava, Y., Prasad, S., Ghosh, S., Kumar, R. S., Bharti, A. C., Singh, R. P., & Nasare, V. D. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149257 · Cited by 7
Chen, Y., Zhao, Y., Aye, L., Wang, Q., Chen, X., Chen, X., & Yang, K. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s522381 · Cited by 6
NFS1 Plays a Critical Role in Regulating Ferroptosis Homeostasis
Sun, S., Cao, H., Li, X., & Liao, H. (2025) · Biomolecules · doi:10.3390/biom16010032 · Cited by 7
Böttcher, M., Reemts, L., Hengeveld, P. J., Loschinski, R., Bhuria, V., Lu, J., Materna‐Reichelt, S., Das, D., Gužvić, N. S., Bruns, H., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02535-x · Cited by 5
Li, J., Wang, Z., Wei, K., Liu, Q., Liang, L., & Lin, J. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118941 · Cited by 5
Shaping death: how the microbiome regulates tumour cell demise and therapy response
Raudenská, M., Balvan, J., Zgarbová, E., Kalfeřt, D., Plzák, J., & Masařík, M. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10318-1 · Cited by 5
IFI16 is essential to linking DNA damage and ferroptosis in acute kidney injury
Qiao, Z., Zhou, D., Zhang, T., Lu, H., Ren, T., Jia, M., He, Z., Han, Y., Lü, C., Wu, J., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08604-5 · Cited by 6
Ma, S., Sun, C., Wang, Y., Zhang, X., & Kuang, H. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02054-5 · Cited by 5
Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy
Xu, X., Wang, X., Jiang, W., Kamaruddin, W. H. A., Fang, C., & Zhang, P. (2026) · BMEMat · doi:10.1002/bmm2.70080 · Cited by 5
Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53
Taritsa, I. C., & Fossel, E. T. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1529483 · Cited by 5
Fan, C.-W., Li, M.-S., Song, X., Luo, L., Jiang, J., Luo, J.-Z., & Wang, H. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117176 · Cited by 5
Unleashing ferroptosis for cancer therapy with warfarin
Liu, X., Zhuang, L., & Gan, B. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.08.008 · Cited by 5
FERREG: ferroptosis-based regulation of disease occurrence, progression and therapeutic response
Zhou, Y., Chen, Z., Yang, M., Chen, F., Yin, J., Zhang, Y., Zhou, X., Sun, X., Ni, Z., Chen, L., et al. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae223 · Cited by 5
Small-molecule MX-C2/3 suppresses non-small cell lung cancer progression via p53 activation
Li, L., Du, W., Wang, H., Zhao, Y., Huang, Z., Peng, Y., Zeng, S., & Zhang, G. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110142 · Cited by 5
Editorial: Novel advances in gastrointestinal cancer treatment
Liu, Y., Guo, S., Yuan, T., & Chen, Y. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1238098 · Cited by 5
Self-citationZou, X., Yang, Y., Yue, B., Yang, H., Yang, Y., Li, M., Du, O., Qiao, G., Wu, Y., Du, J., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70455 · Cited by 4
Liu, X., Wang, J., Liu, Y., Han, Y., Qin, Z., Wang, Y., Gao, S., Li, X., & Suo, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1675373 · Cited by 4
Self-citationLee, J., & Roh, J. (2025) · Cells · doi:10.3390/cells14221800 · Cited by 4
Dai, Y., Wu, C., Zheng, J., Zhao, K., Hua, S., Sun, J., Zhu, H., Luo, J., Shi, J., Han, L., et al. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1774714 · Cited by 4
Ferroptosis in cancer: integrating multi-omics, AI-driven biomarkers, and translational challenges
Taki, A. G., Shareef, A., Arora, V., Oweis, R. J., Jyothi, S. R., Singh, U., Sahoo, S., Chauhan, A. S., Alimova, F., Sameer, H. N., et al. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121131 · Cited by 5
Glutathione-driven redox decisions in cell survival and death
Zhang, R., Kang, R., & Tang, D. (2026) · Vita · doi:10.15302/vita.2026.06.0040 · Cited by 4
Hao, J., Lu, M., Zhao, X., Li, C., Ge, C., Zhang, J., Tu, L., & Zhang, Q. (2024) · Burns · doi:10.1016/j.burns.2024.07.030 · Cited by 4
Liu, F., Wang, Q., Ye, H., Du, Y., Wang, M., Guo, Y., & He, S. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02502-z · Cited by 4
Tan, L., He, G., Shen, C., He, S., Chen, Y., & Guo, X. (2025) · Hereditas · doi:10.1186/s41065-025-00413-8 · Cited by 4
Zuo, X., Wang, X., Xie, J., & Jia, Y. (2025) · International Ophthalmology · doi:10.1007/s10792-025-03513-6 · Cited by 4
Targeting ferroptosis: a novel pathway in oral, oropharyngeal, hypopharyngeal, and laryngeal cancers
Elhami, A., Ghasemzadeh, S., Emrahoglu, S., Ghasemzadeh, N., Mivehchi, H., Beykoylu, M., Ashrafpour, M., Ayoubi, S., & Tabari, M. A. K. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04142-7 · Cited by 4
Tracewell, M., Karlin, J., Barnada, S. M., McDuffie, E., Scott, C. P., Barta, J. A., & McMahon, S. B. (2025) · Carcinogenesis · doi:10.1093/carcin/bgaf027 · Cited by 4
He, W., Meng, Y., Liu, W., & Geng, J. (2025) · The FASEB Journal · doi:10.1096/fj.202402701rr · Cited by 4
Unraveling the Role of Microcystin-LR in Ferroptosis and Sepsis Pathogenesis: A Comprehensive Review
Ying, H., Zhao, H., Zhang, X., Feng, H., Zhou, M., Wu, Z., & Wu, N. (2025) · Biomolecules · doi:10.3390/biom15070947 · Cited by 4
Zhang, J., Geng, W., Sun, H., Chen, J., Fan, Y., & Tan, K. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115557 · Cited by 4
Li, H., Cao, F., Liu, D., & Tao, L. (2025) · Communications Biology · doi:10.1038/s42003-025-08751-z · Cited by 4
Li, W., Xu, H., Li, Y., Shi, X., Ma, Z., Yang, F., & Chen, W. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300168 · Cited by 5
Decoding the power of saponins in ferroptosis regulation and disease intervention: a review
Ouyang, M., Wu, J., Hu, X., Liu, C., & Zhou, D. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae144 · Cited by 4
Tao, L., Xu, J., Jiang, L., Hu, J., & Tang, Z. (2025) · Intensive Care Medicine Experimental · doi:10.1186/s40635-025-00713-3 · Cited by 4
Suchiita, A., Gupta, N., Nandi, K., & Goswami, B. (2025) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2024-0073 · Cited by 4
Gong, Y., Zhang, W., Wang, X., Zheng, S., Liu, H., Lin, Q., Wang, M., Ma, J., Zhang, Y., Li, T., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217815 · Cited by 4
Is loss of p53 a driver of ductal carcinoma in situ progression?
Morrissey, R. L., Thompson, A. M., & Lozano, G. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01885-5 · Cited by 4
Ferroptosis in the pathogenesis of brain tumors
Nikolaev, A. A., & Викторович, Б. В. (2022) · Journal of clinical practice · doi:10.17816/clinpract114787 · Cited by 4
Yao, X., Li, P., Deng, Y., Yang, Y., Luo, H., & He, B. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11947 · Cited by 5
Sridhar, S., Bhalla, P., Kullu, J., Veerapaneni, S., Sahoo, S., Bhatt, N., & Suraishkumar, G. K. (2023) · Metabolic Engineering · doi:10.1016/j.ymben.2023.08.006 · Cited by 8
Editorial: Oxidative stress and distinct cell death
Liu, Y., Duan, Q., & Peng, L. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1292044 · Cited by 4
Self-citationSun, X., Teng, R., Xu, N., Zhang, E., Chen, X., & Li, S. (2025) · Reproductive Toxicology · doi:10.1016/j.reprotox.2025.109099 · Cited by 3
Mahmoud, R., El‐Moslemany, R. M., Abou-Taleb, B. A., El-Mezayen, N. S., Awaad, A. K., & EL-Massik, M. A. E. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126485 · Cited by 3
Li, Z., Song, N., Deng, Y., Zhang, Q., Hu, F., Lu, Y., Chen, J., Xiao, P., Yan, A., Li, J., et al. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102642 · Cited by 3
Wang, Q., Zhang, X., & Xi, L. (2025) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-166600 · Cited by 3
Metabolic Reprogramming and Ferroptosis: Unlocking New Therapeutic Frontiers in Cancer and Diabetes
Huo, Y., Xia, Y., Zhang, Q., Li, Y., Zhao, Y., Li, Z., Zhu, D., Ma, F., Gu, Z., Zhang, N., et al. (2026) · Antioxidants and Redox Signaling · doi:10.1177/15230864261421487 · Cited by 3
Gupta, S. (2026) · npj Systems Biology and Applications · doi:10.1038/s41540-026-00682-7 · Cited by 4
Liu, M., Zeng, C., & Si, Z. (2026) · Pharmaceuticals · doi:10.3390/ph19040629 · Cited by 3
Non-coding RNAs as master regulators of ferroptosis in cancer: mechanisms and clinical implications
Mo, H., Xie, Y., Zhang, H. Z. H., Liu, Y., Wu, W., Xia, Z., Luo, P., Liu, Z., & Cheng, Q. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02666-x · Cited by 3
Self-citationLou, Y., Wu, J., Cheng, S., Wu, G., Guo, L., Yang, F., & Wu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1844850 · Cited by 3
Metal‐dependent regulated cell death: Molecular architecture and translational frontiers
Hu, H., Chen, Z., Li, Y., Peng, J., Cao, J., Zhou, H., Wang, M., Du, Y., Wu, H., Zhao, H., et al. (2026) · iMeta · doi:10.1002/imt2.70141 · Cited by 6
Du, Z., Shi, Y. Y., & Tan, J. (2024) · Briefings in Functional Genomics · doi:10.1093/bfgp/elae025 · Cited by 3
Zhao, H., Li, R., Yu, H., Hao, J., Xu, H., Wang, W., Zhang, Y., Wang, J., Hu, J., Wang, X., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202422357 · Cited by 3
Liu, R., Dai, L., Jia, S., Geng, S., Niu, Y., Chen, J., Dong, C., Li, C., Shi, Y., Wang, X., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.04.025 · Cited by 3
Zhou, C., Xu, Z., Ding, S., Li, X., Wang, H., He, H., Sun, H., Tong, X., Ji, T., Lyu, Y., et al. (2025) · Journal of Applied Toxicology · doi:10.1002/jat.4798 · Cited by 3
Miao, M., Chen, Y., Wang, X., Li, S., & Hu, R. (2025) · Virulence · doi:10.1080/21505594.2025.2497908 · Cited by 4
New Insights on Ferroptosis and Gynecological Malignancies
Fan, R., Sun, Y., Wang, M., Wang, Q., Jiang, A., & Yang, T. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.921298 · Cited by 3
Liu, Y., Wang, Y., Li, C., Feng, H., Liu, Y., & Ma, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1254918 · Cited by 3
Self-citationMao, G., Xu, W., Jamil, M., Zhang, W., Jiao, N., & Liu, Y. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010293337240312051931 · Cited by 3
Self-citationSong, Y., Zhou, D., Zhang, P., Zhu, N., Guo, R., Wang, T., Zhuang, F., & Sun, D. (2024) · Cytotechnology · doi:10.1007/s10616-024-00632-3 · Cited by 4
GBT1118, a Voxelotor Analog, Ameliorates Hepatopathy in Sickle Cell Disease
Haroun, E., Lim, S. H., & Dutta, D. (2024) · Medicina · doi:10.3390/medicina60101581 · Cited by 3
FBR2 modulates ferroptosis via the SIRT3/p53 pathway to ameliorate pulmonary fibrosis
Cheng, Y. W., Jiao, Y., Wei, W., Kou, M., Cai, Y., Li, Y., Li, H., & Liu, T. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1509665 · Cited by 3
Mueed, A., Ma, H., Basit, A., Madjirebaye, P., Ali, A., Khan, S., Li, J., & Deng, Z. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107236 · Cited by 3
Editorial: Role of p53 in cell metabolism, ferroptosis, and stemness
Lu, J., Zhang, Y., Yang, J., Cui, S., Zhang, J., & Liu, Y. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1198641 · Cited by 3
Self-citationWhen CDK4/6i meets GPX4i: Stop dividing to die iron hard
Liang, D., & Jiang, X. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.01.006 · Cited by 2
Exploring Immune-Related Ferroptosis Genes in Thyroid Cancer: A Comprehensive Analysis
Ru, Z., Li, S., Wang, M., Ni, Y., & Qiao, H. (2025) · Biomedicines · doi:10.3390/biomedicines13040903 · Cited by 2
The ferroptosis-ncRNA-exosome triad: key orchestrators in cancer immunopathogenesis
Jabir, M. S., Ahmed, A. T., Hussen, A., Alkhathami, A. G., Rekha, M. M., Sharma, Y., Rani, P., Prasad, G. V. S., & Ahmed, J. K. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04584-z · Cited by 2
Metadata
- Authors
- Liu, Y., & Gu, W.
- Affiliations
- Herbert Irving Comprehensive Cancer Center (US)
- Corresponding author
- Gu, Wei
- ORCID
- Venue
- Cell Death & Differentiation
- Published
- 2022-01-27
- Volume
- 29
- Issue
- 5
- Pages
- 895-910
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- PMC
- PMC9091200
- OpenAlex
- W4210576858
- Cited by
- 540
- References
- 141
- Citations by year
- 2026: 88 · 2025: 153 · 2024: 128 · 2023: 110 · 2022: 60
- FWCI
- 19.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA253059, R01CA254970)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p53, ferroptosis, tumor suppression, GPX4, iron metabolism, reactive oxygen species, non-apoptotic cell death, cancer therapy
- MeSH terms
- Ferroptosis, Humans, Neoplasms, Tumor Suppressor Protein p53, Apoptosis, Reactive Oxygen Species
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review